Black Hawk Acquisition Corp (BKHA) stock
BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU
$8.65+1.45 (+20.14%)
Close on Nov 17, 2026Market cap $35.93MP/E –Yield –
Black Hawk Acquisition ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Black Hawk Acquisition
Black Hawk Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?